CA
LFCR icon

CWC Advisors’s Lifecore Biomedical LFCR Stock Holding History

CWC Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Buy
+87,357
New +$440K 0.2% 105

Other funds holding LFCR

DT
DBA Trading Fort Lauderdale, Florida $199M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MAA
Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
UIA
Ulland Investment Advisors Minneapolis, Minnesota $136M AUM 32.68% 1-Year Est. Return

CWC Advisors's LFCR Position: Q2 2026 in Review

CWC Advisors opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 87,357 shares worth $459K. The stake represents 0.2% of the portfolio and ranks #105 among its holdings.

17 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • CWC Advisors held 87,357 shares of Lifecore Biomedical worth $459K as of Q2 2026.
  • Lifecore Biomedical was a new CWC Advisors position in Q2 2026.
  • Lifecore Biomedical made up 0.2% of CWC Advisors's portfolio in Q2 2026, its #105 holding.
  • 17 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on CWC Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.